Patent ID: 11865138
Assignee: TOPIX PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 1:
2. The dermatological formulation of claim 1, wherein the formulation comprises (% w/w):
water in an amount of 50%-99.8%;
hydrolyzed sodium hyaluronate in an amount of 0%-25%;
sodium hyaluronate in an amount of 1%-10%;
Camellia sinensis leaf extract in an amount of 0%-1%;
ascorbic acid in an amount of 0%-5%;
glycolic acid in an amount of 0%-5%;
lactic acid in an amount of 0%-5%;
benzyl alcohol in an amount of 0%-5%;
ubiquinone in an amount of 0%-0.5%;
bisabolol in an amount of 0%-1%;
a combination of Glycerin, Butylene Glycol, Water, and Tetrapeptide-21 in an amount of 0%-10%;
a combination of glycerin, butylene glycol, carbomer, polysorbate 20, and palmitoyl pentapeptide-4 in an amount of 0%-10%;
glutathione in an amount of 0%-1%;
superoxide dismutase in an amount of 0%-5%;
phenoxyethanol in an amount of 0%-2%;
sodium benzoate in an amount of 0%-0.5%; and
disodium EDTA in an amount of 0%-0.2%.